Servye Rus of Servier Rus

History

2019

Launch of drug labeling system

In December 2019, Servier became one of the first companies to successfully launch a drug labeling and traceability system.

Launch of Dolutegravir production line for HIV treatment

On April 25, 2019, it became known that in Moscow, a drug production line for the treatment of HIV infection was launched at the Servier pharmaceutical plant. The official opening was attended by the head of the Department of Investment and Industrial Policy of Moscow Alexander Prokhorov.

The launch of the line involves the production of a full cycle of a ready-made dosage form - the drug Dolutegravir - for the treatment of HIV infection.

This is not the first drug for the treatment of HIV infection, localized at production sites in Russia. For us, this is a signal that Moscow provides optimal conditions for doing business, launching production lines. In particular, due to the status of the industrial complex, Servier RUS received a number of benefits, which, in turn, allowed it to invest about 130 million rubles in the production of a vital drug.

The benefits that Servier RUS has received since 2016 have allowed the company to save about 31 million rubles. According to him, as of April 2019, the pharmaceutical industry has 6 industrial complexes from 30 enterprises, as well as 9 research organizations. The industry employs 10.5 thousand people. According to the results of 2018, the total volume of goods shipped amounted to 115.4 billion rubles and the volume of investments in the fixed assets of pharmaceutical companies amounted to 3.8 billion rubles.

The production agreement is concluded for a period of 5 years and provides for a flexible scope of the production plan, which will fully satisfy the need for this drug in Russia.

Servier RUS LLC is one of the active participants in the April 2019 pilot project on drug labeling. Modern packaging line equipment for Dolutegravir production fully complies with the Russian regulatory marking requirements.

2016: Assigning the plant the status "Industrial Complex"

In 2016, the Moscow Government granted the Servier RUS plant the status of an Industrial Complex.

2012: First exports from Russia to CIS countries

In 2012, the first export of medicines produced in Russia was carried out to the CIS countries.

2007: Launch of production in New Moscow

In 2007, a high-tech full-cycle production complex was launched in New Moscow, operating in full compliance with the requirements of the international standard of good production practice (GMP) and producing a wide range of modern original medicines for Russian citizens.

1999: Moscow Center for Research and Development

Servier has been operating in Russia since the 1990s, being one of the leading pharmaceutical companies. In 1999, the Center for Scientific Research and Development of the company was opened in Moscow.